Societal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022

Rhea-AI Summary

Societal CDMO, Inc. (SCTL) will announce its third-quarter 2022 financial results after the market close on November 9, 2022. The management will discuss the results and operational highlights during a webcast at 4:30 p.m. ET on the same day. Interested parties can access the live event via the Investor Events page on Societal's website. The archived webcast will be available for 30 days post-event. Societal CDMO specializes in contract development and manufacturing, focusing on small molecule therapeutic development.

Positive

• Scheduled release of third-quarter 2022 financial results, expected to provide insights into company performance.
• Management will discuss operational highlights, potentially indicating growth or improvements.

Negative

• None.

Webcast Scheduled for Wednesday, November 9, 2022, at 4:30 p.m. Eastern

SAN DIEGO and GAINESVILLE, Ga., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the third quarter 2022 after the market close on Wednesday, November 9, 2022. Societal’s management team will host a webcast at 4:30 p.m. ET on Wednesday, November 9, 2022, to discuss the financial results and recent operational highlights.

A live webcast can be accessed by visiting the “Investor Events” page in the Investor section of the company’s website: https://ir.societalcdmo.com/events. In addition, an archived webcast will be available on the company’s website approximately two hours after the event and will be available for 30 days.

About Societal CDMO
Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.

Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.

FAQ

When will Societal CDMO (SCTL) release its third-quarter 2022 financial results?

Societal CDMO will release its third-quarter 2022 financial results on November 9, 2022, after market close.

What time is the Societal CDMO (SCTL) webcast for financial results?

The webcast for Societal CDMO's financial results is scheduled for 4:30 p.m. ET on November 9, 2022.

Where can I access the Societal CDMO (SCTL) financial results webcast?

The live webcast can be accessed on the Investor Events page of Societal CDMO's website.

Will the Societal CDMO (SCTL) webcast be available later?

Yes, an archived version of the webcast will be available on Societal CDMO's website for 30 days after the event.